Metadata language
Title:
Long follow-up of children with congenital heart defect from Kraków voivodship born in 1987-89
Author:
Subject:
follow-up ; treatment results ; congenital heart defect
Abstract:
Incidence of congenital heart defect (CHD) varies from 2/1000 to 50/1000, depending on patient’s age, diagnostic methods, definition of CHO and length of follow-up. In continuation of epidemiological studies carried on in 1987-89 further observation or the population under study was done. Until end of 2003, 56 new cases of CHO were diagnosed (Gr. I), in comparison to l Il diagnosed in 1987-89 (Gr.11). In Gr. I Atrial septal defect (ASD) and aortic stenosis (AS) were more frequent, and Fallot's syndrome (TOF) less frequent. ASD was diagnosed more frequently in girls, coarctation of aorta in boys. The reason of delayed detection were faint symptoms and no circulatory disturbances. Delayed diagnosis had not caused deterioration neither course nor the outcome of treatment. In both groups the most frequent was ventricular septal defect, (33.93% in Gr. I and 4S.02% in Gr. II). then in Gr. I ASD (23.43%, AS (23.12%), persistent Botall's duet (PDA) (8.93%) and pulmonary stenosis (PS) (7.14%), in Gr. II: PS (9.65%), PDA (8.93%), ASD (8.36%) and AS (4.50%). Other types of CHD were less common. In both groups 55% of cases were diagnosed in neonates. 27% in the first 12 months, 2.7% in second year. 15 .3% later. All cyanotic defects and those with circulatory disturbances were diagnosed in the first year of live. Congestive heart failure was more frequent in Gr II in the beginning with no ; difference between groups in the end of follow-up. In the Gr. II spontaneous involution of CHO was observed more frequently. There was no difference in the frequency of invasive treatment in both groups (131 cases), out of them further follow-up in necessary mare often on Gr. II, and in 10.7% pharmacotherapy is introduced. In group of 236 treated conservatively, treatment was completed in 52.5%, 30.9% is in follow-up (mare often in Gr I, 3.8% is treated pharmacologically. The risk of death is higher in Gr. II and in boys.